Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Trial of Neoadjuvant Chemotherapy and Surgery Versus Concurrent Chemoradiation Therapy in Patients With Stage IB2-IIB Squamous Carcinoma of the Uterine Cervix

NCT00193739 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT00193739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00193739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Trial of Neoadjuvant Chemotherapy and Surgery Versus Concurrent Chemoradiation Therapy in Patients With Stage IB2-IIB Squamous Carcinoma of the Uterine Cervix
Lead sponsor
Tata Memorial Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
September 4, 2003
Completion date
July 31, 2020
Enrollment
635 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of cervix